Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update
Go back to Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.19 +0.04 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $19.62 | |||
| Open | $2.10 | 52 Week Low | $7.65 | |||
| Day High | $2.24 | P/E | N/A | |||
| Day Low | $2.06 | EPS | $-0.22 | |||
| Volume | 1,987,614 | |||||
